hit-toques.com

Wednesday, April 7, 2021

Wikinews extended invitations by e-mail on March 23 to multiple candidates running in the Texas’ 6th congressional district special election of May 1 to fill a vacancy left upon the death of Republican congressman Ron Wright. Of them, independent candidate Adrian Mizher agreed to answer some questions by phone on March 30 about their campaigns and policies. The following is the interview with Mr Mizher.

Mizher describes himself as a senior loan closer on his LinkedIn profile at BBVA USA, a Birmingham-based subsidiary of Banco Bilbao Vizcaya Argentaria. He has lived in Kennedale, Texas for five years and the Dallas-Fort Worth metropolitan area for 16 of the last 24 years. A cum laude graduate of Southwestern Adventist University, he grew up in Philadelphia, Pennsylvania and has lived for eight years in Albuquerque, New Mexico. He endeavours to bring “a never ending fight for fidelity to the Constitution and promotion of our Conservative values”, speaking to Wikinews on matters ranging from the economy to immigration.

An Inside Elections poll published on March 18 shows Republican candidate Susan Wright, the widow of Ron Wright, is ahead by 21% followed by Democrat Jana Sanchez with 17% and Republican Jake Ellzey with 8% with a 4.6% margin of error among 450 likely voters. The district is considered “lean Republican” by Inside Elections and voted 51% in favour of Donald Trump in last year’s US presidential election. This is down from 54% for Trump in 2016’s presidential election, the same poll stated.

Thursday, December 18, 2008

A team of eight transplant surgeons in Cleveland Clinic in Ohio, USA, led by reconstructive surgeon Dr. Maria Siemionow, age 58, have successfully performed the first almost total face transplant in the US, and the fourth globally, on a woman so horribly disfigured due to trauma, that cost her an eye. Two weeks ago Dr. Siemionow, in a 23-hour marathon surgery, replaced 80 percent of her face, by transplanting or grafting bone, nerve, blood vessels, muscles and skin harvested from a female donor’s cadaver.

The Clinic surgeons, in Wednesday’s news conference, described the details of the transplant but upon request, the team did not publish her name, age and cause of injury nor the donor’s identity. The patient’s family desired the reason for her transplant to remain confidential. The Los Angeles Times reported that the patient “had no upper jaw, nose, cheeks or lower eyelids and was unable to eat, talk, smile, smell or breathe on her own.” The clinic’s dermatology and plastic surgery chair, Francis Papay, described the nine hours phase of the procedure: “We transferred the skin, all the facial muscles in the upper face and mid-face, the upper lip, all of the nose, most of the sinuses around the nose, the upper jaw including the teeth, the facial nerve.” Thereafter, another team spent three hours sewing the woman’s blood vessels to that of the donor’s face to restore blood circulation, making the graft a success.

The New York Times reported that “three partial face transplants have been performed since 2005, two in France and one in China, all using facial tissue from a dead donor with permission from their families.” “Only the forehead, upper eyelids, lower lip, lower teeth and jaw are hers, the rest of her face comes from a cadaver; she could not eat on her own or breathe without a hole in her windpipe. About 77 square inches of tissue were transplanted from the donor,” it further described the details of the medical marvel. The patient, however, must take lifetime immunosuppressive drugs, also called antirejection drugs, which do not guarantee success. The transplant team said that in case of failure, it would replace the part with a skin graft taken from her own body.

Dr. Bohdan Pomahac, a Brigham and Women’s Hospital surgeon praised the recent medical development. “There are patients who can benefit tremendously from this. It’s great that it happened,” he said.

Leading bioethicist Arthur Caplan of the University of Pennsylvania withheld judgment on the Cleveland transplant amid grave concerns on the post-operation results. “The biggest ethical problem is dealing with failure — if your face rejects. It would be a living hell. If your face is falling off and you can’t eat and you can’t breathe and you’re suffering in a terrible manner that can’t be reversed, you need to put on the table assistance in dying. There are patients who can benefit tremendously from this. It’s great that it happened,” he said.

Dr Alex Clarke, of the Royal Free Hospital had praised the Clinic for its contribution to medicine. “It is a real step forward for people who have severe disfigurement and this operation has been done by a team who have really prepared and worked towards this for a number of years. These transplants have proven that the technical difficulties can be overcome and psychologically the patients are doing well. They have all have reacted positively and have begun to do things they were not able to before. All the things people thought were barriers to this kind of operations have been overcome,” she said.

The first partial face transplant surgery on a living human was performed on Isabelle Dinoire on November 27 2005, when she was 38, by Professor Bernard Devauchelle, assisted by Professor Jean-Michel Dubernard in Amiens, France. Her Labrador dog mauled her in May 2005. A triangle of face tissue including the nose and mouth was taken from a brain-dead female donor and grafted onto the patient. Scientists elsewhere have performed scalp and ear transplants. However, the claim is the first for a mouth and nose transplant. Experts say the mouth and nose are the most difficult parts of the face to transplant.

In 2004, the same Cleveland Clinic, became the first institution to approve this surgery and test it on cadavers. In October 2006, surgeon Peter Butler at London‘s Royal Free Hospital in the UK was given permission by the NHS ethics board to carry out a full face transplant. His team will select four adult patients (children cannot be selected due to concerns over consent), with operations being carried out at six month intervals. In March 2008, the treatment of 30-year-old neurofibromatosis victim Pascal Coler of France ended after having received what his doctors call the worlds first successful full face transplant.

Ethical concerns, psychological impact, problems relating to immunosuppression and consequences of technical failure have prevented teams from performing face transplant operations in the past, even though it has been technically possible to carry out such procedures for years.

Mr Iain Hutchison, of Barts and the London Hospital, warned of several problems with face transplants, such as blood vessels in the donated tissue clotting and immunosuppressants failing or increasing the patient’s risk of cancer. He also pointed out ethical issues with the fact that the procedure requires a “beating heart donor”. The transplant is carried out while the donor is brain dead, but still alive by use of a ventilator.

According to Stephen Wigmore, chair of British Transplantation Society’s ethics committee, it is unknown to what extent facial expressions will function in the long term. He said that it is not certain whether a patient could be left worse off in the case of a face transplant failing.

Mr Michael Earley, a member of the Royal College of Surgeon‘s facial transplantation working party, commented that if successful, the transplant would be “a major breakthrough in facial reconstruction” and “a major step forward for the facially disfigured.”

In Wednesday’s conference, Siemionow said “we know that there are so many patients there in their homes where they are hiding from society because they are afraid to walk to the grocery stores, they are afraid to go the the street.” “Our patient was called names and was humiliated. We very much hope that for this very special group of patients there is a hope that someday they will be able to go comfortably from their houses and enjoy the things we take for granted,” she added.

In response to the medical breakthrough, a British medical group led by Royal Free Hospital’s lead surgeon Dr Peter Butler, said they will finish the world’s first full face transplant within a year. “We hope to make an announcement about a full-face operation in the next 12 months. This latest operation shows how facial transplantation can help a particular group of the most severely facially injured people. These are people who would otherwise live a terrible twilight life, shut away from public gaze,” he said.

Wednesday, June 16, 2021

In early May, Wikinews extended an invitation to Vitaly Filipchenko, an independent candidate in the 2021 New York City mayoral election, set to take place November 2nd, alongside other candidates. Filipchenko answered some questions about his policies and campaign during a phone interview.

Filipchenko, registered on the New York City Campaign Finance Board as Vitaly A. Filipchenko, is the first Russian candidate for New York City mayor, being born in Tomsk, Siberia in 1973, according to news agency Sputnik. He has since naturalised as a United States citizen. According to the web site, Filipchenko has been educated in road construction and maintenance and owns a moving services company; he describes himself on his web site as a “small business owner”. On his web site’s platform page, he says that “[m]y English may not be perfect – but my platform is.”

Incumbent Democrat mayor Bill de Blasio, who won re-election in the 2017 New York City mayoral election by 66.5%, cannot run for a third term under term limits. As of April 28, 22 candidates are currently running, the majority of whom are also Democrats. Ahead of the June Democratic primary for New York City mayor, a poll conducted May 23 and 24 by WPIX and Emerson College of 12 Democratic candidates with a margin of error of 3.2 per cent has former commissioner for the New York City Department of Sanitation Kathryn Garcia and Borough President of Brooklyn Eric Adams leading with 21.1% and 20.1%, respectively.

Sunday, July 24, 2005

The World Health Organization’s Beijing spokesman has said that the People’s Republic of China has withheld vital information regarding H5N1 outbreaks, a type of bird flu that is infecting animals throughout Asia. The animals most affected by the disease are those among waterfowl and poultry, however in recents months it has infected humans and has also been discovered in tigers as well as swine. The Nation magazine quotes WHO officials as saying that the strain has the potential of causing a human pandemic (global epidemic) resulting in tens of millions of deaths.

The first appearance of this type of flu was in Hong Kong during 1997. As of July 21, 2005, one hundred and nine cases of human infection have been confirmed resulting in fifty five deaths outside of China reports the Centers for Disease Control. China has reported no deaths in the recent outbreaks, leading to speculation of a cover up. The Economist says eleven countries across Asia have been affected, and more than one hundred and twenty million birds have died from infection or been culled. Although this week a case was found in Russia making it the first European country with an infection and twelfth in the world.

Usually these flu viruses are carried worldwide by wild bird populations in their intestines and are non-lethal. However this variant has mutated into the most lethal strain of influenza ever recorded says Mike Davis, author of The Monster at Our Door: The Global Threat of Avian Flu. Such occurrences are natural and have happened in the past as in the 1918 Spanish influenza pandemic.

The current virus is morphing into a type that is spread among humans with the first human-to-human cases found in Vietnam during 2005. When avian influenza subtypes adapt for this mode of transmission the effect is deadly for humans as the immune system has no natural immunities for it and the production of appropriate antibodies to fight the infection takes some time.

Further complicating the effort to combat H5N1, it was reported in the Washington Post that the People’s Republic of China has been administering the medication Amantadine to poultry in violation of international livestock regulations that state it is for human use only since the late-1990s (all the time officially denying any cases of bird flu among its poultry); the result has been that the virus is now largely immune to the medication and is significantly deadlier. World Health Organization officials had been preparing to use the drug to fight a future pandemic and now it has been rendered useless.

Chinese government officials have said more than 1,000 migratory birds have been found dead during 2005 and there have been unofficial Internet reports of one hundred and twenty related human fatalities that are strongly denied by Beijing.

China has previously irked international agencies for its handling of public and agricultural health crises, notably the SARS epidemic that began in 2002. China’s health minister was fired after the government acknowledged it had covered up the extent of the SARS outbreak by preventing reports about the illness for months and by minimizing its seriousness says the Washgington Post.

Margaret Chan, WHO director of pandemic influenza preparedness is pressing China to allow laboratories to examine specimens from birds in Qinghai, where the H5N1 virus has killed more than 5,000 birds from five species. Recombinomics has found Chinese message boards indicating part of Qinghai province may be under martial law and quarantine.

Three outbreaks of H5N1 have affected China in recent months but the World Health Organization has not received the information or the virus samples from infected birds that they requested. “It is a matter of urgency,” said Roy Wadia, the WHO’s speaker in China. “We stress that this virus is highly unpredictable and versatile and can change any time. It is highly dangerous.”